Products for Research Use Only
RegisterLogin

SAR228810

CAT: 0804-HY-P991654Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991654Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SAR228810 is a humanized IgG4 monoclonal antibody inhibitor targeting amyloid β (Aβ) with a KD of 0.43 nM for protofibrillar Aβ over monomeric Aβ. SAR228810 significantly inhibits the brain amyloid plaque formation and oligomer-induced synaptic dysfunction and neurite loss. SAR228810 has significant protection against Aβ-mediated neuritotoxicity. MINT1526A can be used for Alzheimer’s disease imaging and immunotherapy research[1][2].
UNSPSC
12352100
Target
Amyloid-β
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
References & Citations
[1]Wang Z, et al. Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer's disease immunotherapeutics. Acta Neuropathol Commun. 2023 Mar 10;11 (1) :39. |[2]Pradier L, et al. SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA) . Alzheimers Res Ther. 2018 Nov 28;10 (1) :117.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T9901A-1849-01SAR228810
PTX25472Anti-Human APP/Amyloid beta (SAR228810)
WA1182Research Grade Anti-Human APP/Amyloid beta (SAR228810)
A135730Anti-APP/Amyloid beta (SAR228810) Biosimilar (Monoclonal, IgG)

Popular Products